Literature DB >> 7817548

Fecal occult blood testing for colorectal cancer in an ethnically diverse population.

G A Glober1, S Hundahl, J Stucke, M Choy.   

Abstract

Fecal occult blood test kits were distributed throughout the ethnically diverse Hawaiian Islands during a 3-week period in 1989. Occult blood was detected in 1,631 persons (11.8%). At least 83% of the participants with positive tests sought medical advice. Subsequently, 76 (4.7%) were diagnosed as having colorectal adenomas and an additional 1.4% had malignant neoplasms (3 gastric and 20 colorectal adenocarcinomas). Three quarters of the colorectal cancers were localized and node-negative. Participation in this program and the type of diagnostic studies done on participants with positive tests varied according to sex and ethnicity. Therefore, these demographic variables must be considered in designing fecal occult blood screening programs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817548      PMCID: PMC1022617     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  28 in total

1.  Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.

Authors:  M J Barry; A G Mulley; J M Richter
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

2.  Results of a public screening program for colorectal cancer.

Authors:  K M Cummings; A Michalek; J Tidings; L Herrera; C Mettlin
Journal:  N Y State J Med       Date:  1986-02

3.  Results of a television-advertised public screening program for colorectal cancer.

Authors:  T J McGarrity; P A Long; L P Peiffer; J O Converse; A F Kreig
Journal:  Arch Intern Med       Date:  1989-01

4.  Improved community colorectal cancer control, Kauai.

Authors:  N G Sutherland; R Miller; T C Hall
Journal:  Hawaii Med J       Date:  1983-08

5.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.

Authors:  K M Cummings; A Michalek; C Mettlin; A Mittelman
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

7.  Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.

Authors:  O Kronborg; C Fenger; O Søndergaard; K M Pedersen; J Olsen
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

8.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

Review 9.  Detection and surveillance of colorectal cancer.

Authors:  D E Fleischer; S B Goldberg; T H Browning; J N Cooper; E Friedman; F H Goldner; E B Keeffe; L E Smith
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

10.  Hemoccult screening for colorectal cancer.

Authors:  F C Chang; T M Jackson; C R Jackson
Journal:  Am J Surg       Date:  1988-12       Impact factor: 2.565

View more
  1 in total

1.  Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics.

Authors:  Ala Szczepura; Charlotte Price; Anil Gumber
Journal:  BMC Public Health       Date:  2008-10-02       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.